Belgian specialty pharmaceutical company Hyloris Pharmaceuticals SA is getting ready to launch an Initial...
Up To Date
Latest News
An analysis of 1.500 tumours demonstrates that different human tumour types each harbour their own unique...
Based on genetic data, a new diagnostic algorithm can differentiate between five different rheumatic diseases.
Novo Holdings leads the current US$60m Series C round of ExScientia Ltd, the world-leading artificial...
Metabolic disease specialist Poxel SA has announced a private placement of 2,358,483 new ordinary shares at...
Share
